News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ClinTec GmbH Hosts Lord Provost Sadie Docherty at Glasgow HQ as CRO Formally Launches Master's Degree


6/20/2013 6:47:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

20th June 2013: ClinTec International, a global CRO with a presence in over 40 countries worldwide, welcomed Glasgow’s Lord Provost Sadie Docherty to its UK Headquarters in Glasgow on Tuesday to mark the formal launch of the company’s MSc in International Clinical Research and Technology in collaboration with Edinburgh Napier University.

The company’s CEO and founder, Dr Rabinder Buttar, was delighted to host the Lord Provost and other dignitaries from the world of education and clinical research to the event, which marked the first intake of students for the innovative and pioneering three year course: the first of its kind to be launched by a UK based CRO. Already students from thirteen different countries (Austria, Czech Republic, France, India, Lebanon, Lithuania, Philippines, Russia, Slovenia, South Africa, Sweden, and the UK) have enrolled for the course. Speaking at the event, Dr Buttar commented; “We are extremely proud and honoured to welcome the Lord Provost to our Glasgow Headquarters. It marks an important day in the company’s 17 year history. The launch of this Master’s degree shows the commitment we have towards nurturing the talent of the future. We have always been an advocate of employing talented, bright, and resourceful graduates from all across the globe, so this course is something to be extremely proud of. The clinical research market is constantly evolving with new markets and trends emerging year after year. It is my hope that this course will give candidates the tools and knowledge they require in order to be successful after graduation. We as a company have always had a broad outlook, as our recent expansion into Turkey has shown, so it is my hope that we will see candidates from all corners of the world enrolling.”

Lord Provost Sadie Docherty also praised the course. She said: “This is a great example of business and educational institutions collaborating, and working together. Scotland has contributed a great deal to the pharmaceutical industry over the past 150 years. I am confident this course will strengthen that tradition. It is great to know that students from across the globe are keen to enrol on this course. Ultimately this will benefit students, ClinTec, Edinburgh Napier University and Scotland.”

The degree has been developed in collaboration with Edinburgh Napier University, an institution with a proven track record of providing innovative under and post graduate qualifications in clinical research to both a UK and International audience. Taught by experts in the field from both the university and ClinTec’s experienced global team, the Masters course is designed for Clinical Research Professionals, and will be delivered online on a part time basis through an interactive learning platform or in person at ENU campuses. This will mean the course can be fitted around a busy work and home life, with lectures being able to be viewed live, or after the lecture has occurred.

Bobby Bal, Senior Director, Corporate Development,

Glasgow, Scotland, UK.

Phone: +44 (0)141 226 1120

Fax: +44 (0)141 248 8993

Email : bbal@clintec.com

www.clintec.com

For media enquiries, please contact Tristan Jervis on +44 (0) 207 203 6740. E-mail: t.jervis@defacto.com

About ClinTec International

ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US. In addition to ClinTec’s vast expertise in oncology, the organisation has also conducted over 300 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec’s fast, flexible and focused approach to clinical research ensures an added advantage to the drug development process.

Tristan Jervis

Managing Partner

Holborn Gate, 26 Southampton Buildings

London WC2A 1BP

Telephone: +44 (0)207 203 6742

Direct: +44 (0)207 203 6740

E-mail: t.jervis@defacto.com

www.defacto.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES